| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of vitamin D metabolites by liquid chromatography-tandem mass spectrometry
|
van den Ouweland, Johannes M.W.
|
|
2016
|
84 |
PB |
p. 117-130
14 p.
|
artikel
|
| 2 |
Clinical peptide and protein quantification by mass spectrometry (MS)
|
Grebe, Stefan K.G.
|
|
2016
|
84 |
PB |
p. 131-143
13 p.
|
artikel
|
| 3 |
Current status of non-targeted liquid chromatography-tandem mass spectrometry in forensic toxicology
|
Oberacher, Herbert
|
|
2016
|
84 |
PB |
p. 94-105
12 p.
|
artikel
|
| 4 |
Design and utility of open-access liquid chromatography tandem mass spectrometry in quantitative clinical toxicology and therapeutic drug monitoring
|
Grant, Russell P.
|
|
2016
|
84 |
PB |
p. 51-60
10 p.
|
artikel
|
| 5 |
From targeted quantification to untargeted metabolomics: Why LC-high-resolution-MS will become a key instrument in clinical labs
|
Rochat, Bertrand
|
|
2016
|
84 |
PB |
p. 151-164
14 p.
|
artikel
|
| 6 |
Hyphenation of fast liquid chromatography with high-resolution mass spectrometry for quantitative proteomics analyses
|
Lesur, Antoine
|
|
2016
|
84 |
PB |
p. 144-150
7 p.
|
artikel
|
| 7 |
Impact of LC-MS/MS on the laboratory diagnosis of catecholamine-producing tumors
|
Eisenhofer, Graeme
|
|
2016
|
84 |
PB |
p. 106-116
11 p.
|
artikel
|
| 8 |
Knowing the unknown – State of the art of LCMS in toxicology
|
Rentsch, Katharina M.
|
|
2016
|
84 |
PB |
p. 88-93
6 p.
|
artikel
|
| 9 |
LC-MS/MS for Therapeutic Drug Monitoring of anti-infective drugs
|
Veringa, Anette
|
|
2016
|
84 |
PB |
p. 34-40
7 p.
|
artikel
|
| 10 |
Liquid chromatography tandem mass spectrometry for therapeutic drug monitoring of immunosuppressive drugs: Achievements, lessons and open issues
|
Shipkova, Maria
|
|
2016
|
84 |
PB |
p. 23-33
11 p.
|
artikel
|
| 11 |
MALDI-TOF MS entering the microbiological diagnostic laboratory – from fast identification to resistance testing
|
Wieser, Andreas
|
|
2016
|
84 |
PB |
p. 80-87
8 p.
|
artikel
|
| 12 |
Mass spectrometry – a key technique for traceability in clinical chemistry
|
Kessler, Anja
|
|
2016
|
84 |
PB |
p. 74-79
6 p.
|
artikel
|
| 13 |
Mass spectrometry in the therapeutic drug monitoring of direct oral anticoagulants. Useful or useless?
|
Douxfils, Jonathan
|
|
2016
|
84 |
PB |
p. 41-50
10 p.
|
artikel
|
| 14 |
Mass spectrometry methods in clinical diagnostics – state of the art and perspectives
|
Vogeser, Michael
|
|
2016
|
84 |
PB |
p. 1-4
4 p.
|
artikel
|
| 15 |
Opening the toolbox of alternative sampling strategies in clinical routine: A key-role for (LC-)MS/MS
|
Velghe, Sofie
|
|
2016
|
84 |
PB |
p. 61-73
13 p.
|
artikel
|
| 16 |
The emerging role of multiplex tandem mass spectrometry analysis for therapeutic drug monitoring and personalized medicine
|
Decosterd, L.A.
|
|
2016
|
84 |
PB |
p. 5-13
9 p.
|
artikel
|
| 17 |
Therapeutic Drug Monitoring for individualised risk reduction in psychopharmacotherapy
|
Schütze, Gregor
|
|
2016
|
84 |
PB |
p. 14-22
9 p.
|
artikel
|
Tijdschrift beschrijving